siRNA

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: SiranBio and GSK SA030 Licensing Agreement

Lucid Diligence Brief: SiranBio and GSK SA030 Licensing Agreement Professional…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Arrowhead ARO-PNPLA3 licensed to Madrigal

Lucid Diligence Brief: Arrowhead ARO-PNPLA3 licensed to Madrigal Professional…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Moonwalk Biosciences pivots from CRISPR-based epigenetic editing to siRNA obesity therapies

Lucid Diligence Brief: Moonwalk Biosciences pivots from CRISPR-based epigenetic…

by Timos Papagatsias

Cell_Gene_Therapy

Cell and Gene Therapy Today—November 20, 2025

This weekly Cell & Gene Therapy update spans regulatory actions, durable…

by LucidQuest

ASGCT 2025 PREVIEW: Key Cell and Gene Therapy Highlights to Watch

ASGCT 2025 at a glance Count down to ASGCT 2025 with LucidQuest’s brief…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.